Reuters logo
BRIEF-Mabvax Therapeutics announces $4.1 million public offering
May 15, 2017 / 10:10 PM / in 7 months

BRIEF-Mabvax Therapeutics announces $4.1 million public offering

May 15 (Reuters) - Mabvax Therapeutics Holdings Inc

* Mabvax Therapeutics announces $4.1 million public offering

* Mabvax Therapeutics Holdings - Offering consists of 1.3 million shares of common stock, aggregate of 1,000,000 shares of 0% Series G convertible preferred stock

* Mabvax Therapeutics Holdings - 1.3 million shares, 1,000,000 shares of 0% Series G convertible preferred stock priced at $1.75 per share Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below